MNKD
MANNKIND CORP
NASDAQ · Healthcare · Biotechnology · US
$3.54
−1.12%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 147.96x
- P/E 2028E
- 59.10x
- P/S forward
- 2.22x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -16.94x
- Price / sales
- 2.89x
- Price / cash flow
- -134.12x
Enterprise value
- Enterprise value
- $1.4B
- EV / sales
- 3.45x
- EV / EBITDA
- 44.17x
- EV / EBIT
- 175.13x
- Market cap
- $1.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026